Preoperative Systemic Immune–Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I–II Gastric Cancer After Radical Surgery

BACKGROUND: Systemic immune–inflammation index (SII), calculated by immunoinflammatory cell counts of peripheral blood, is considered a predictor of survival outcome in several solid tumors, including gastric cancer (GC). However, there is no study focusing on the prognostic value of SII in the earl...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Kang, Si, Lixiang, Pan, Xiaohua, Sun, Ling, Wang, Yajing, Lu, Jianwei, Wang, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918673/
https://www.ncbi.nlm.nih.gov/pubmed/35296020
http://dx.doi.org/10.3389/fonc.2022.829689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918673/
https://www.ncbi.nlm.nih.gov/pubmed/35296020
http://dx.doi.org/10.3389/fonc.2022.829689

Ejemplares similares